Research output: Contribution to journal › Article › peer-review
Zara J. Franklin, Anastasia Tsakmaki, Patricia Fonseca Pedro, Aileen J. King, Guo Cai Huang, Sakeena Amjad, Shanta J. Persaud, Gavin A. Bewick
Original language | English |
---|---|
Journal | Diabetes, obesity & metabolism |
Early online date | 6 Nov 2017 |
DOIs | |
Accepted/In press | 16 Sep 2017 |
E-pub ahead of print | 6 Nov 2017 |
Additional links |
NPY receptors and beta cell survival DOM 2017
DOM_YR_paper_Revision_1.pdf, 526 KB, application/pdf
Uploaded date:25 Sep 2017
Version:Accepted author manuscript
Licence:CC BY-ND
Aims: Two unmet therapeutic strategies for diabetes treatment are prevention of beta-cell death and stimulation of beta-cell replication. Our aim was to characterize the role of neuropeptide Y receptors in the control of beta-cell mass. Materials and Methods: We used endogenous and selective agonists of the NPY receptor system to explore its role in the prevention of beta-cell apoptosis and proliferation in islets isolated from both mouse and human donors. We further explored the intra-cellular signalling cascades involved, using chemical inhibitors of key signalling pathways. As proof of principle we designed a long-acting analogue of [Leu31Pro34]-NPY, an agonist of the islet-expressed Y receptors, to determine if targeting this system could preserve beta-cell mass in vivo. Results: Our data reveal that NPY Y1, 4 and 5 receptor activation engages a generalized and powerful anti-apoptotic pathway that protects mouse and human islets from damage. These anti-apoptotic effects were dependent on stimulating a Gαi-PLC-PKC signalling cascade, which prevented cytokine-induced NFkB signalling. NPY receptor activation functionally protected islets by restoring glucose responsiveness following chemically induced injury in both species. NPY receptor activation attenuated beta-cell apoptosis, preserved functional beta-cell mass and attenuated the hyperglycaemic phenotype in a low-dose streptozotocin model of diabetes. Conclusion: Taken together, our observations identify the islet Y receptors as promising targets for the preservation of beta-cell mass. As such, targeting these receptors could help to maintain beta-cell mass in both type 1 and type 2 diabetes, and may also be useful for improving islet transplantation outcomes.
King's College London - Homepage
© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454